Cargando…

High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin

BACKGROUND: Epilepsy is a neurological disorder with a multitude of underlying causes, which may include infection with Onchocerca volvulus, the parasitic worm that causes human onchocerciasis. A survey carried out in 1989 revealed a high prevalence of epilepsy (1.02% overall, ranging from 0.51 to 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mmbando, Bruno P., Suykerbuyk, Patrick, Mnacho, Mohamed, Kakorozya, Advocatus, Matuja, William, Hendy, Adam, Greter, Helena, Makunde, Williams H., Colebunders, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009039/ https://www.ncbi.nlm.nih.gov/pubmed/29921319 http://dx.doi.org/10.1186/s40249-018-0450-3

Ejemplares similares

Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania
por: Kaiser, Christoph, et al.
Publicado: (2019)

Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years
por: Greter, Helena, et al.
Publicado: (2018)

Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania
por: Bhwana, Dan, et al.
Publicado: (2022)

High Prevalence of Glaucoma among Patients in an Onchocerciasis Endemic Area (Mahenge, Tanzania)
por: Otiti-Sengeri, Juliet, et al.
Publicado: (2022)

Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study
por: Bhwana, Dan, et al.
Publicado: (2023)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial
por: Colebunders, Robert, et al.
Publicado: (2017)

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
por: Abd-Elfarag, Gasim, et al.
Publicado: (2018)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso
por: Nikièma, Achille S., et al.
Publicado: (2021)

Nodding syndrome, a case-control study in Mahenge, Tanzania: Onchocerca volvulus and not Mansonella perstans as a risk factor
por: Amaral, Luís-Jorge, et al.
Publicado: (2023)

High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
por: Lenaerts, Evy, et al.
Publicado: (2018)

High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo
por: Levick, Bethany, et al.
Publicado: (2017)

Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo
por: Dolo, Housseini, et al.
Publicado: (2018)

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
por: Otabil, Kenneth Bentum, et al.
Publicado: (2023)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
por: Boullé, Charlotte, et al.
Publicado: (2019)

Low ivermectin use among 5- to 6-year-old children: observations from door-to-door surveys in onchocerciasis-endemic regions in Africa
por: Siewe Fodjo, J N, et al.
Publicado: (2019)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial
por: Mandro, Michel, et al.
Publicado: (2020)

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
por: O’Neill, Sarah, et al.
Publicado: (2019)

Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study
por: Mandro, Michel, et al.
Publicado: (2018)

‘Slash and clear’ vector control for onchocerciasis elimination and epilepsy prevention: a protocol of a cluster randomised trial in Cameroonian villages
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2021)

Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2020)

High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment
por: Mukendi, Deby, et al.
Publicado: (2019)

Onchocerciasis Prevalence among Persons with Epilepsy in an Onchocerciasis Hypo-Endemic Area in the Democratic Republic of Congo: A Cross-Sectional Study
por: Hotterbeekx, An, et al.
Publicado: (2021)

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
por: Siewe, Joseph N. F., et al.
Publicado: (2019)

Onchocerciasis‐associated epilepsy: From recent epidemiological and clinical findings to policy implications
por: Colebunders, Robert, et al.
Publicado: (2017)

Report of the first international workshop on onchocerciasis-associated epilepsy
por: Colebunders, Robert, et al.
Publicado: (2018)

Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
por: Ekpo, Uwem F., et al.
Publicado: (2022)

Implementation Challenges of Community Directed Treatment with Ivermectin Program for Control of Onchocerciasis in Ulanga, Tanzania
por: Mushi, Vivian
Publicado: (2021)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
por: Gumisiriza, Nolbert, et al.
Publicado: (2020)

Drawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa
por: Amuyunzu-Nyamongo, Mary, et al.
Publicado: (2011)

Potential Parasitic Causes of Epilepsy in an Onchocerciasis Endemic Area in the Ituri Province, Democratic Republic of Congo
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis
por: Makunde, William H, et al.
Publicado: (2003)

Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
por: Otabil, Kenneth Bentum, et al.
Publicado: (2023)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan: A community-based survey
por: Colebunders, Robert, et al.
Publicado: (2018)

Epidemiology of epilepsy and relationship with onchocerciasis prevalence in villages of the Ntui Health District of Cameroon
por: Ngarka, Leonard, et al.
Publicado: (2023)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2018)

Epilepsy in the Sanaga‐Mbam valley, an onchocerciasis‐endemic region in Cameroon: electroclinical and neuropsychological findings
por: Morin, Alexandre, et al.
Publicado: (2021)

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
por: Colebunders, Robert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o0hkei20340e2420p7911kfif0